Impact of Excercise and Physical Therapy on Quality of Life in People with Migraine

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Sports Medicine and Sports Traumatology".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1541

Special Issue Editors


E-Mail Website
Guest Editor
1. Faculty of Medicine, University of Belgrade, Belgrade, Serbia
2. University Children's Hospital, Belgrade, Serbia
Interests: electrodiagnostics; rehabilitation; population genetics; physical activity
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Biomedical Sciences, State University of Novi Pazar, 36300 Novi Pazar, Serbia
2. Asir Rehabilitation Center, 6473 Abha, Asir, Saudi Arabia
Interests: public health

Special Issue Information

Dear Colleagues,

Migraine presents significant public health burden. This condition presents central nervous system (CNS) disorder affecting nerves and blood vessels. Previously it was stated that migraine presents risk factor for cardiovascular diseases. Persons with migraine can have multiple benefits from physical therapy along with medicamentous treatment, including musculoskeletal malfunctions improvements particularly in cranial and cervical regions, decrease in pain during the attack temporarily and improve vestibular symptoms. The importance of exercise for individuals with migraine is significant, since it was stressed that moderate exercise might have an influence on migraine frequency reduction as well as its severity. However, people with migraine usually report the physical activity as a potential trigger for attack, thus reducing such activity.

The purpose of this Special Issue is to present advances and innovations in exercise impact on migraine prevention and improvement of symptoms as well as the role of physical therapy in migraine course that would lead to the improvement of overall quality of life in these individuals.

Prof. Dr. Dejan P. Nikolić
Prof. Dr. Natasa Radosavljević
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • migraine
  • physical therapy
  • exercise
  • quality of life

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

14 pages, 1309 KiB  
Study Protocol
Intramuscular Electrical Stimulation for the Treatment of Trigger Points in Patients with Chronic Migraine: A Protocol for a Pilot Study Using a Single-Case Experimental Design
by Thomas Perreault, Lars Arendt-Nielson, César Fernández-de-las-Peñas, Jan Dommerholt, Pablo Herrero and Ryan Hubbard
Medicina 2023, 59(8), 1380; https://doi.org/10.3390/medicina59081380 - 28 Jul 2023
Viewed by 1332
Abstract
Background and Objectives: Trigger points (TrPs) are prevalent in patients with migraine headaches. Needling interventions targeting TrPs in migraine patients may reduce the intensity and frequency of headaches, yet systematic reviews reveal a lack of robust evidence. Intramuscular electrical stimulation (IMES) is a [...] Read more.
Background and Objectives: Trigger points (TrPs) are prevalent in patients with migraine headaches. Needling interventions targeting TrPs in migraine patients may reduce the intensity and frequency of headaches, yet systematic reviews reveal a lack of robust evidence. Intramuscular electrical stimulation (IMES) is a modality that delivers electrical current into muscles and TrPs, with recent studies suggesting it may amplify the therapeutic effects of dry needling peripherally and centrally. This could be advantageous for patients with migraine and symptomatic TrPs. Materials and Methods: This study will implement a multiple baseline single-case experimental design (SCED). In a clinical setting, a SCED study lends itself to conducting research with only a few patients that each serve as their own controls. In this SCED study, four participants with chronic migraine will be enrolled in a non-concurrent manner and randomized to one of four baseline measurement periods (4, 5, 6 or 7 weeks), leading to four potentially different start dates for each participant in the intervention phase. During the intervention phase, patients will receive five sessions of dry needling with IMES, one session per week for five weeks. The primary outcome measure will be headache frequency, i.e., the reduction in the number of headache days over a one-month period using electronic headache diary data from the Migraine Buddy smartphone application. Secondary outcome measures will be changes in mean migraine pain intensity using a numeric pain rating scale (NPRS), migraine disability using the Migraine Disability Assessment Test (MIDAS), the Headache Impact Test (HIT-6), and changes in selected cervical musculoskeletal impairments including pressure pain thresholds (PPTs) over TrPs, the craniocervical flexion test (CCFT), and cervical active range of motion (AROM). Primary and secondary outcome measures will be analyzed separately using both visual and statistical analyses. Results: Actively recruiting participants. This project was approved by the Mass General Brigham Institutional Review Board (protocol #2023P000931) and is registered with ClinicalTrials.gov (NCT05893914). Conclusions: This study will seek to determine the effects of a five-week intervention period of IMES to TrPs in the posterior cervical muscles of subjects with chronic migraine. Full article
Show Figures

Figure 1

Back to TopTop